This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/8/2024
Operator
Conference Operator
Good day, everyone, and thank you for standing by.
Kimberly Manhart
Welcome to the Acadia Pharmaceuticals first quarter 2024 financial results and operating overview conference call.
Operator
Conference Operator
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session.
You're reading a preview of the ACAD Q1 2024 earnings call.
Free account.
Disclaimer